Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quality of Recovery |
184; 187; 185 | — |
| SECONDARY Nausea and Vomiting During PACU Staying |
3; 9; 9 | — |
| SECONDARY Number of Participants With Pruritus |
4; 7; 8 | — |
| SECONDARY Pain During Postanesthesia Care Unit and Ward Stay (Numeric Rating Scale - NRS) |
0; 5; 2 | — |
Eligibility Criteria
Inclusion Criteria
- ASA physical status I or II, who will scheduled to undergo surgical treatment of lower limb fractures
Exclusion Criteria
Patients who:
(i) refused to participate in the study;
(ii) were not able to communicate due to alterations in the level of consciousness, or neurologic, or psychiatric disease;
(iii) presented with contraindication to any of the drugs used in the present study;
(iv) had history of alcohol or drug abuse and
(v) had surgery in the last 10 days were excluded.
Reasons for exclusion after randomisation will be protocol violations or if the anesthesia technique was changed from a spinal to a general approach.
Data sourced from ClinicalTrials.gov (NCT03035942). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.